Tapewire

NYSE · USD

JNJ

JOHNSON & JOHNSON

Export transactions ↓
Tapewire entity
2722
SEC CIK
0000200406
Parsed reports
1,771

Last 12 months

Inside the activity.

1 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202602
Feb 2026015
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 08, 2026 Filed Sep 11, 2026 00:51 UTC GrantDeferred Share Units · Derivative 113.098 $276.31 $31,250.11
Disclosure

SEC source: 0000200406-26-000185 · wk-form4_1789087875.xml · derivative · entry 1

Pinto Daniel E · CIK 0001555174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,445.177

Underlying: Common Stock · 113.098 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
September 08, 2026 Filed Sep 11, 2026 00:50 UTC GrantDeferred Share Units · Derivative 135.717 $276.31 $37,499.96
Disclosure

SEC source: 0000200406-26-000184 · wk-form4_1789087843.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,578.771

Underlying: Common Stock · 135.717 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
September 08, 2026 Filed Sep 11, 2026 00:50 UTC GrantDeferred Share Units · Derivative 180.956 $276.31 $49,999.95
Disclosure

SEC source: 0000200406-26-000183 · wk-form4_1789087809.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,049.417

Underlying: Common Stock · 180.956 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 13:08 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 22,527 $0.00 Strike: $151.41 $0.00
Disclosure

SEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · derivative · entry 8

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,527 shares

Expires 2030-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 13:08 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 11,070 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · derivative · entry 7

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,070 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 13:08 UTC
Schmid TimothyEVP, WW Chair, MedTech
SaleCommon Stock 22,527 $274.74 $6,189,067.98
Disclosure

SEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · nonDerivative · entry 4

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,447

Read SEC document
September 02, 2026 Filed Sep 4, 2026 13:08 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionCommon Stock 22,527 $151.41 $3,410,813.07
Disclosure

SEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · nonDerivative · entry 3

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,974

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 13:08 UTC
Schmid TimothyEVP, WW Chair, MedTech
SaleCommon Stock 11,070 $274.74 $3,041,371.80
Disclosure

SEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · nonDerivative · entry 2

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,447

Read SEC document
September 02, 2026 Filed Sep 4, 2026 13:08 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionCommon Stock 11,070 $131.94 $1,460,575.80
Disclosure

SEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · nonDerivative · entry 1

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,517

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 22:31 UTC
Taubert Jennifer LEVP, WWC. Innovative Medicine
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 15,000 $0.00 Strike: $115.67 $0.00
Disclosure

SEC source: 0000200406-26-000175 · wk-form4_1787092263.xml · derivative · entry 3

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,712

Underlying: Common Stock · 15,000 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 22:31 UTC
Taubert Jennifer LEVP, WWC. Innovative Medicine
SaleCommon Stock 15,000 $263.36 $3,950,400.00
Disclosure

SEC source: 0000200406-26-000175 · wk-form4_1787092263.xml · nonDerivative · entry 2

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,451.001

F1 · price: This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 22:31 UTC
Taubert Jennifer LEVP, WWC. Innovative Medicine
Exercise / conversionCommon Stock 15,000 $115.67 $1,735,050.00
Disclosure

SEC source: 0000200406-26-000175 · wk-form4_1787092263.xml · nonDerivative · entry 1

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,451.001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 13, 2026 Filed Aug 14, 2026 20:35 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 123,291 $0.00 Strike: $115.67 $0.00
Disclosure

SEC source: 0000200406-26-000173 · wk-form4_1786739711.xml · derivative · entry 6

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 123,291 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
August 13, 2026 Filed Aug 14, 2026 20:35 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
SaleCommon Stock 102,315 $261.00 $26,704,215.00
Disclosure

SEC source: 0000200406-26-000173 · wk-form4_1786739711.xml · nonDerivative · entry 3

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,967

Read SEC document
August 13, 2026 Filed Aug 14, 2026 20:35 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
SaleCommon Stock 20,976 $262.00 $5,495,712.00
Disclosure

SEC source: 0000200406-26-000173 · wk-form4_1786739711.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,282

Read SEC document
August 13, 2026 Filed Aug 14, 2026 20:35 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionCommon Stock 123,291 $115.67 $14,261,069.97
Disclosure

SEC source: 0000200406-26-000173 · wk-form4_1786739711.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:44 UTC
Forminard ElizabethEVP, Chief Legal Officer
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 9,344 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0000200406-26-000169 · wk-form4_1786139073.xml · derivative · entry 4

Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,344 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:44 UTC
Forminard ElizabethEVP, Chief Legal Officer
SaleCommon Stock 6,574 $255.93 $1,682,496.97
Disclosure

SEC source: 0000200406-26-000169 · wk-form4_1786139073.xml · nonDerivative · entry 3

Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,994

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:44 UTC
Forminard ElizabethEVP, Chief Legal Officer
SaleCommon Stock 9,344 $257.76 $2,408,462.72
Disclosure

SEC source: 0000200406-26-000169 · wk-form4_1786139073.xml · nonDerivative · entry 2

Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,568

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:44 UTC
Forminard ElizabethEVP, Chief Legal Officer
Exercise / conversionCommon Stock 9,344 $131.94 $1,232,847.36
Disclosure

SEC source: 0000200406-26-000169 · wk-form4_1786139073.xml · nonDerivative · entry 1

Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 05, 2026 Filed Aug 7, 2026 21:50 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
SaleCommon Stock 6,523 $258.74 $1,687,754.50
Disclosure

SEC source: 0000200406-26-000171 · wk-form4_1786139443.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,967

F2 · price: This transaction was executed in multiple trades at prices ranging from $258.535 to $259.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 05, 2026 Filed Aug 7, 2026 21:50 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
SaleCommon Stock 41,957 $258.06 $10,827,255.59
Disclosure

SEC source: 0000200406-26-000171 · wk-form4_1786139443.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,490

F1 · price: This transaction was executed in multiple trades at prices ranging from $257.53 to $258.505. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 20, 2026 Filed Jul 21, 2026 21:27 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 11,925 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0000200406-26-000148 · wk-form4_1784669273.xml · derivative · entry 5

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,925 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
July 20, 2026 Filed Jul 21, 2026 21:27 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 11,129 $0.00 Strike: $129.51 $0.00
Disclosure

SEC source: 0000200406-26-000148 · wk-form4_1784669273.xml · derivative · entry 4

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,129 shares

Expires 2028-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
July 20, 2026 Filed Jul 21, 2026 21:27 UTC
Broadhurst VanessaEVP, Global Corp Affairs
SaleCommon Stock 23,054 $251.27 $5,792,686.36
Disclosure

SEC source: 0000200406-26-000148 · wk-form4_1784669273.xml · nonDerivative · entry 3

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,003

F1 · price: This transaction was executed in multiple trades at prices ranging from $251.09 to $251.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 20, 2026 Filed Jul 21, 2026 21:27 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionCommon Stock 11,925 $131.94 $1,573,384.50
Disclosure

SEC source: 0000200406-26-000148 · wk-form4_1784669273.xml · nonDerivative · entry 2

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 20, 2026 Filed Jul 21, 2026 21:27 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionCommon Stock 11,129 $129.51 $1,441,316.79
Disclosure

SEC source: 0000200406-26-000148 · wk-form4_1784669273.xml · nonDerivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 11, 2026 Filed Jun 12, 2026 21:23 UTC
Wengel Kathryn EEVP, Chief TO and Risk Officer
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 10,000 $0.00 Strike: $115.67 $0.00
Disclosure

SEC source: 0000200406-26-000127 · wk-form4_1781299408.xml · derivative · entry 5

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,965

Underlying: Common Stock · 10,000 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
June 11, 2026 Filed Jun 12, 2026 21:23 UTC
Wengel Kathryn EEVP, Chief TO and Risk Officer
SaleCommon Stock 10,000 $241.15 $2,411,500.00
Disclosure

SEC source: 0000200406-26-000127 · wk-form4_1781299408.xml · nonDerivative · entry 2

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,287.8735

F1 · price: This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 11, 2026 Filed Jun 12, 2026 21:23 UTC
Wengel Kathryn EEVP, Chief TO and Risk Officer
Exercise / conversionCommon Stock 10,000 $115.67 $1,156,700.00
Disclosure

SEC source: 0000200406-26-000127 · wk-form4_1781299408.xml · nonDerivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,287.8735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:35 UTC GrantDeferred Share Units · Derivative 214.786 $232.79 $50,000.03
Disclosure

SEC source: 0000200406-26-000121 · wk-form4_1781210156.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,791.877

Underlying: Common Stock · 214.786 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:43 UTC GrantDeferred Share Units · Derivative 134.241 $232.79 $31,249.96
Disclosure

SEC source: 0000200406-26-000123 · wk-form4_1781210616.xml · derivative · entry 1

Pinto Daniel E · CIK 0001555174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,320.824

Underlying: Common Stock · 134.241 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:56 UTC GrantDeferred Share Units · Derivative 161.089 $232.79 $37,499.91
Disclosure

SEC source: 0000200406-26-000125 · wk-form4_1781211401.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,411.959

Underlying: Common Stock · 161.089 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
May 01, 2026 Filed May 4, 2026 20:58 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Exercise / conversionRestricted Share Units · Derivative 25,255 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000115 · wk-form4_1777928336.xml · derivative · entry 3

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

Read SEC document
May 01, 2026 Filed May 4, 2026 20:58 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Tax withholdingCommon Stock 11,002 $229.85 $2,528,809.70
Disclosure

SEC source: 0000200406-26-000115 · wk-form4_1777928336.xml · nonDerivative · entry 2

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,911

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
May 01, 2026 Filed May 4, 2026 20:58 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Exercise / conversionCommon Stock 25,255 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000115 · wk-form4_1777928336.xml · nonDerivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:38 UTC GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000092 · wk-form4_1777325899.xml · derivative · entry 1

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,797.7393

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:43 UTC GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000094 · wk-form4_1777326205.xml · derivative · entry 1

Doudna Jennifer A · CIK 0001739090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,899.1714

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:48 UTC GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000096 · wk-form4_1777326520.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,487.939

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:01 UTC GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000098 · wk-form4_1777327261.xml · derivative · entry 1

Johnson Paula A · CIK 0001341161 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,359.3973

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:05 UTC
Joly HubertDirector
GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000100 · wk-form4_1777327547.xml · derivative · entry 1

Joly Hubert · CIK 0001467638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,183.605

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:06 UTC GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000102 · wk-form4_1777327601.xml · derivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,278.593

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:12 UTC GrantDeferred Share Units · Derivative 1,540 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000104 · wk-form4_1777327934.xml · derivative · entry 1

MORIKIS JOHN G · CIK 0001203523 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,540

Underlying: Common Stock · 1,540 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:13 UTC GrantDeferred Share Units · Derivative 1,712 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000106 · wk-form4_1777328012.xml · derivative · entry 1

Pinto Daniel E · CIK 0001555174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,174.069

Underlying: Common Stock · 1,712 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:17 UTC GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000108 · wk-form4_1777328237.xml · derivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,010.408

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:21 UTC
West NadjaDirector
GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000111 · wk-form4_1777328506.xml · derivative · entry 1

West Nadja · CIK 0001787802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,730.0491

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:23 UTC GrantDeferred Share Units · Derivative 975 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000113 · wk-form4_1777328617.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,215.094

Underlying: Common Stock · 975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
March 10, 2026 Filed Mar 13, 2026 00:37 UTC GrantDeferred Share Units · Derivative 154.869 $242.14 $37,499.98
Disclosure

SEC source: 0000200406-26-000067 · wk-form4_1773362248.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,240.094

Underlying: Common Stock · 154.869 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
March 10, 2026 Filed Mar 13, 2026 00:39 UTC GrantDeferred Share Units · Derivative 129.058 $242.14 $31,250.10
Disclosure

SEC source: 0000200406-26-000069 · wk-form4_1773362378.xml · derivative · entry 1

Pinto Daniel E · CIK 0001555174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 462.069

Underlying: Common Stock · 129.058 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
March 10, 2026 Filed Mar 13, 2026 01:31 UTC GrantDeferred Share Units · Derivative 206.492 $242.14 $49,999.97
Disclosure

SEC source: 0000200406-26-000070 · wk-form4_1773365486.xml · derivative · entry 2

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,512.94

Underlying: Common Stock · 206.492 shares

Expires not disclosed

F3 · derivative.exercise_price: Acquisition of DSUs for deferral of cash retainer under the Plan.

F3 · derivative.exercise_date: Acquisition of DSUs for deferral of cash retainer under the Plan.

F3 · derivative.expiration_date: Acquisition of DSUs for deferral of cash retainer under the Plan.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.